Compumedics Ltd (ASX: CMP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Compumedics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$56.05 million
P/E Ratio
45.71
Dividend Yield
0.00%
Shares Outstanding
183.77 million
Earnings per share
0.007
Dividend per share
N/A
Year To Date Return
7.14%
Earnings Yield
2.19%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Compumedics Ltd (ASX: CMP)
Latest News
Share Market News
Why this ASX healthcare share just downgraded its guidance
52-Week Highs
Why these ASX shares just surged to 52-week highs
Share Gainers
Compumedics share price rockets 26% higher on FDA news
Share Fallers
Why ARB, Compumedics, Coronado Global, Integrated Research are tumbling lower
Share Market News
Why the Compumedics share price is crashing 22% lower on Monday
Share Market News
3 results you might have missed on Thursday
Share Gainers
These 3 small cap shares are on the rise today
Share Fallers
Why these 4 ASX shares have started the week in the red
Share Fallers
Why the Compumedics Limited (ASX:CMP) share price has been smashed today
⏸️ Investing
These 3 small cap shares are on the rise today
⏸️ Investing
Why these small cap shares are racing higher today
⏸️ Investing
Why these 4 ASX shares jumped higher today
1❯
CMP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Compumedics Ltd
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.
CMP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 01 Nov 2024 | $0.31 | $0.00 | 0.00% | 53,920 | $0.31 | $0.31 | $0.29 |
| 31 Oct 2024 | $0.31 | $0.02 | 6.90% | 140,646 | $0.29 | $0.31 | $0.29 |
| 30 Oct 2024 | $0.29 | $-0.01 | -3.33% | 112,330 | $0.30 | $0.30 | $0.29 |
| 29 Oct 2024 | $0.30 | $-0.01 | -3.28% | 1,923 | $0.30 | $0.30 | $0.30 |
| 28 Oct 2024 | $0.31 | $0.00 | 0.00% | 28,769 | $0.31 | $0.31 | $0.31 |
| 25 Oct 2024 | $0.31 | $0.01 | 3.39% | 6,071 | $0.31 | $0.31 | $0.31 |
| 23 Oct 2024 | $0.30 | $0.01 | 3.45% | 30,382 | $0.30 | $0.30 | $0.30 |
| 22 Oct 2024 | $0.29 | $-0.01 | -3.33% | 92,119 | $0.30 | $0.30 | $0.29 |
| 21 Oct 2024 | $0.30 | $-0.02 | -6.35% | 31,084 | $0.32 | $0.32 | $0.30 |
| 18 Oct 2024 | $0.32 | $0.00 | 0.00% | 85,703 | $0.32 | $0.32 | $0.30 |
| 17 Oct 2024 | $0.32 | $0.01 | 3.28% | 639,453 | $0.32 | $0.32 | $0.32 |
| 16 Oct 2024 | $0.31 | $0.01 | 3.33% | 22,213 | $0.29 | $0.31 | $0.29 |
| 14 Oct 2024 | $0.30 | $-0.01 | -3.28% | 159,630 | $0.31 | $0.31 | $0.30 |
| 11 Oct 2024 | $0.31 | $-0.02 | -6.15% | 66,395 | $0.32 | $0.33 | $0.31 |
| 10 Oct 2024 | $0.33 | $0.01 | 3.13% | 36,691 | $0.32 | $0.33 | $0.32 |
| 09 Oct 2024 | $0.32 | $0.01 | 3.17% | 52,181 | $0.31 | $0.32 | $0.30 |
| 08 Oct 2024 | $0.32 | $-0.01 | -3.13% | 3,200 | $0.32 | $0.32 | $0.32 |
| 07 Oct 2024 | $0.32 | $0.02 | 6.56% | 95,798 | $0.30 | $0.32 | $0.30 |
| 03 Oct 2024 | $0.31 | $-0.01 | -3.23% | 18,167 | $0.29 | $0.31 | $0.29 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr David Burton | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 1987 |
Dr. Burton's engineering background includes the design and project management of the Compumedics' first sleep laboratory and portable sleep systems. Dr. Burton has authored fifteen patents or patent applications that form part of Compumedics' intellectual property. Experience in the development, design, manufacture and sale of medical devices and the development of the business. Other current directorships D & DJ Burton Holdings Pty Ltd; Intellirad Pty Ltd; Electro Molecular Pty Ltd.
|
| Mr David Lawson | Chief Financial OfficerCompany SecretaryExecutive Director | Oct 2013 |
Mr Lawson has experience in the development of the Compumedics business over the last 25 years and prior to that held a number of management positions with another listed public entity.
|
| Mr Rod James North | Non-Executive Director | Oct 2022 |
Mr North has been working in the financial services & corporate sector for 30 years, having held roles in share broking, investment and funds management and provided investor relations, media & PR services to a range of ASX listed companies over the past 18 years. He has experience in company analysis and financial management. He has served on investment committees in funds management. He has also acted in corporate advisory roles to private and public companies at senior executive and board level, advising on capital raisings, communication, and investor relations strategies.
|
| Warwick Freeman | Chief Technology Officer |
-
|
|
| Dr. Dieter Grossegger | Compumedics alpha trace |
-
|
|
| Christoph Witte | General Managing Director DWL Compumedics Germany GmbH |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| D & Dj Burton Holdings Pty Ltd | 96,002,819 | 52.24% |
| HSBC Custody Nominees (Australia) Limited | 10,488,473 | 5.71% |
| B & R James Investments Pty Limited <James Superannuation A/C> | 7,290,000 | 3.97% |
| Beijing Bestmed Tech Ltd | 4,901,961 | 2.67% |
| Medigas Italia S R L | 4,333,333 | 2.36% |
| Mr David Francis Lawson & Ms Michelle Gabrielle Callinan <Lawson Callinan Super A/C> | 2,464,482 | 1.34% |
| Electro Molecular Pty Ltd | 2,041,500 | 1.11% |
| Valui Pty Ltd <Fortis Super Fund A/C> | 1,830,987 | 1.00% |
| Ms Karin Jones | 1,209,576 | 0.66% |
| Knowler Property Pty Ltd | 1,198,000 | 0.65% |
| Mr Bernard Frederick Knowler & Mrs Robynne Lynette Knowler <Knowler Family A/C> | 1,120,000 | 0.61% |
| Bfa Super Pty Ltd <Gdn Super Fund A/C> | 1,078,188 | 0.59% |
| Mr Mark David Holder | 1,061,299 | 0.58% |
| Mr Nigel Strong | 1,008,786 | 0.55% |
| Mr David Francis Lawson | 1,006,242 | 0.55% |
| Jarvsofaks Pty Ltd <De Lisio Super Fund A/C> | 953,970 | 0.52% |
| Avianto Pty Ltd <Hock Soo Mee Super A/C> | 934,000 | 0.51% |
| Zigsuper Pty Ltd <Ziguras Super Fund A/C> | 900,000 | 0.49% |
| Mr Bruce Dennis Lusty & Mrs Jan Denise Lusty <The Licentia A/C> | 791,883 | 0.43% |
| Canucki Pty Ltd <Canuckinoz Fund A/C> | 757,069 | 0.41% |
